XML 37 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Convertible preferred stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Loss [Member]
Treasury Stock [Member]
Balance at Beginning at Dec. 31, 2020 $ 776 $ 7,935 $ 28 $ 14,166 $ (21,353) $ 0 $ 0
Balance at Beginning (in Shares) at Dec. 31, 2020   6,687,475 37,366,865        
Issuance of common stock upon exercise of stock options 1,830   $ 2 1,828   0 0
Issuance of common stock upon exercise of stock options, shares     2,368,705        
Issuance of restricted stock awards, shares     24,895        
Share-based compensation expense 3,409     3,409      
Issuance of common stock from initial public offering, net of issuance costs and underwriting discount 107,610   $ 7 107,603      
Issuance of common stock from initial public offering, net of issuance costs and underwriting discount     6,953,125        
Issuance of common stock upon net exercise of warrants     $ 1 (1)      
Issuance of common stock upon net exercise of warrants, shares     621,570        
Conversion of convertible preferred stock and accrued dividends on convertible preferred stock into common stock   $ (7,935) $ 7 7,928      
Conversion of convertible preferred stock and accrued dividends on convertible preferred stock into common stock, shares   (6,687,475) 6,845,922        
Net loss (20,552)       (20,552)    
Balance at Ending at Dec. 31, 2021 93,073 $ 0 $ 45 134,933 (41,905) 0 0
Balance at Ending (in Shares) at Dec. 31, 2021   0 54,181,082        
Issuance of common stock upon exercise of stock options 2,187   $ 10 2,177     0
Issuance of common stock upon exercise of stock options, shares     1,444,626        
Common stock issued for vesting of stock units     2,500        
Share-based compensation expense 8,111     8,111      
Net loss (42,815)       (42,815)    
Unrealized loss on available-for-sale marketable securities (27) $ 0          
Unrealized loss on available-for-sale marketable securities           (27)  
Balance at Ending at Dec. 31, 2022 60,529 $ 0 $ 55 145,221 (84,720) (27) 0
Balance at Ending (in Shares) at Dec. 31, 2022   0 55,628,208        
Issuance of common stock upon exercise of stock options $ 1,869   $ 1 1,868      
Issuance of common stock upon exercise of stock options, shares 495,337   495,337        
Common stock issued for vesting of stock units     149,919        
Share-based compensation expense $ 17,363     17,363      
Issuance of common stock from initial public offering, net of issuance costs and underwriting discount 107,527   $ 6 107,521      
Issuance of common stock from initial public offering, net of issuance costs and underwriting discount     5,476,190        
Net loss (49,527)       (49,527)    
Unrealized loss on available-for-sale marketable securities 190         190  
Shares directly withheld from employees for tax payment (13)           (13)
Balance at Ending at Dec. 31, 2023 $ 137,938 $ 0 $ 62 $ 271,973 $ (134,247) $ 163 $ (13)
Balance at Ending (in Shares) at Dec. 31, 2023   0 61,749,654